Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/1/2022
NMPA Solicits Comments on the Provisions on Facilitating Main Responsi...
11/30/2022
WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...
11/30/2022
NMPA Issues the List of Drugs Prohibited for Online Sales (Unofficial ...
11/30/2022
NMPA Issues the Announcement on Regulating the Filing and Reporting of...
11/29/2022
Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
11/29/2022
Fosun Weighs Sale of Indian Drugmaker Gland Pharma - Bloomberg
11/29/2022
A Slow October Sees Deals in Novel Therapies with New Technologies (Ph...
11/28/2022
What Does Biden's Directive on Foreign Biotech Investments Mean for Ma...
11/28/2022
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Pep...
11/28/2022
China Is to Begin Formal Access Negotiation for the 2022 NRDL
11/26/2022
CAR-T Therapies See New Competitors Emerge in October (PharmaDJ)
11/25/2022
Recent Executive Moves
11/25/2022
CK Life Sciences Teams Up with XtalPi to Develop Cancer Vaccines
11/24/2022
IQVIA: Chinese Hospital Drug Market Steady in MAT Q3/2022
11/23/2022
Jinyao Pharma Fined CNY 27.72M for Additional Monopoly Violation
11/23/2022
WuXi AppTec Begins Construction of Wuxi STA's East China R&D Facility
11/23/2022
GlobalData: Chinese Manufacturers' Transition to Innovative Pharma Req...
11/23/2022
NMPA and Chinese Customs Announce Addition of Shijiazhuang Airport as ...
11/23/2022
Hainan Issues New Policy to Improve Drug Import Process
11/23/2022
Umoja Biopharma and IASO Biotherapeutics Enter Partership for Off-the-...
11/22/2022
Measures for Supervision and Administration of Online Sales of Drugs: ...
11/21/2022
Biotech CEO Interview: Harbour BioMed's Wang On Moderna Deal, New Subs...
11/21/2022
Performance of A Share-listed MedPharm Cos Improved in Q3/2022
11/18/2022
Recent Executive Moves
11/17/2022
Marinus Pharma and Tenacia Biotech Tie Up for Ganaxolone Development ...
11/16/2022
Kinarus Therapeutics Engages Great Health Companion Group to Explore P...
11/16/2022
NHC Reorganizes Medical Administration Departments to Emphasize Epidem...
11/16/2022
Harbour Biomed Launches Nona Biosciences to Provide "Ideas to IND" Pre...
11/15/2022
NMPA Holds Conference on Promotion of Foreign Trade and Investment
11/15/2022
Biotheus and Hansoh Strike Licensing Deal for its EGFR/MET Bispecific ...
Page:
34
/
333
Total number of articles:
9989
:
[First]
[<<]
[32]
[33]
[34]
[35]
[36]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit